The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Treatment (trx) patterns of angiogenesis inhibitors in patients (pts) with metastatic renal cell carcinoma (mRCC) in Ireland.
Raymond S. McDermott
No relevant relationships to disclose
Paul P. Donnellan
No relevant relationships to disclose
John McCaffery
No relevant relationships to disclose
Sujata P. Sarda
No relevant relationships to disclose
Caroline Korves
No relevant relationships to disclose
Andi Luka
No relevant relationships to disclose
Robert Wei
No relevant relationships to disclose
Maureen Neary
No relevant relationships to disclose
Riona Hanley
No relevant relationships to disclose
Mei Sheng Duh
No relevant relationships to disclose